AMED Ventures
Description
AMED Ventures is a San Francisco-based venture capital firm singularly focused on investing in entrepreneurs and disruptive MedTech innovations. The firm's core mission revolves around identifying and supporting companies that are developing advanced medical technologies aimed at significantly improving patient outcomes and transforming the broader healthcare landscape. Their investment thesis is deeply rooted in the belief that scientific breakthroughs, coupled with strong entrepreneurial vision, can lead to impactful solutions in the medical field.
The firm's investment strategy is comprehensive, spanning from early-stage to growth-stage companies. AMED Ventures seeks to partner with exceptional founders, providing not only crucial capital but also strategic guidance and operational support to accelerate the growth and market penetration of their portfolio companies. This hands-on approach leverages the deep industry expertise of its leadership team, which includes Managing Partners Dr. Amir Nashat, also a Partner at Polaris Partners, and Dr. Edward Lanphier, a co-founder of Sangamo BioSciences. Their backgrounds suggest a strong emphasis on scientific rigor and commercialization potential.
AMED Ventures typically deploys first checks ranging from $500,000 to $5,000,000, making them a significant early to growth-stage investor in the MedTech space. According to industry databases, the firm has made approximately 10 investments to date, focusing on areas such as biotechnology, medical devices, and therapeutics. This focused portfolio reflects their specialized expertise and commitment to the healthcare sector. Their strategic location in San Francisco, a hub for biotech and innovation, further positions them to access cutting-edge opportunities within the MedTech ecosystem.
Investor Profile
AMED Ventures has backed more than 25 startups, with 3 new investments in the last 12 months alone. The firm has led 1 rounds, about 4% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical Device, Medical.
- Led 1 rounds in the past year.
- Typical check size: $500K – $5M.
Stage Focus
- Series B (28%)
- Series C (20%)
- Series Unknown (16%)
- Series D (12%)
- Series E (12%)
- Series A (12%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Biotechnology
- Commercial
- Health Diagnostics
- Advanced Materials
- Manufacturing
- Software
- Life Science
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
